Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Staar Surgical (STAA)
NASDAQ:STAA
Holding STAA?
Track your performance easily
STAA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$26.66 - $52.68
Previous Close$37.23
Volume2.22M
Average Volume (3M)830.84K
Market Cap
$1.83B
Enterprise Value$1.63B
Total Cash (Recent Filing)$235.20M
Total Debt (Recent Filing)$36.27M
Price to Earnings (P/E)111.1
Beta1.42
Next Earnings
Oct 30, 2024EPS Estimate
$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.34
Shares Outstanding49,188,211
10 Day Avg. Volume1,118,822
30 Day Avg. Volume830,839
Standard Deviation0.18
R-Squared0.03
Alpha0.00965
Financial Highlights & Ratios
Price to Book (P/B)4.47
Price to Sales (P/S)5.50
Price to Cash Flow (P/CF)-44.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.90
Enterprise Value/Gross Profit6.46
Enterprise Value/Ebitda88.99
Forecast
1Y Price Target
$43.00Price Target Upside15.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Staar Surgical News
PremiumCompany Announcements
STAAR Surgical Posts Strong Q3 2024 Financial Results
PremiumCompany Announcements
Staar Surgical Achieves 10% Sales Growth, Income Doubles
Bulls Say, Bears Say
Bulls Say
Guidance IncreaseThe company raised its guidance for FY24 related to the US, now projecting growth of 25% year-over-year.
Market AdoptionU.S. growth outlook was raised to 25% year-over-year from the prior 10% year-over-year, reflecting strong performance and increased adoption.
Revenue GrowthSTAA had a strong Q2 in the US, with 24.6% year-over-year revenue growth.
Bears Say
Financial PerformanceSoft ophthalmic procedure demand and a weaker consumer in China could lead to downside to STAA's estimates over the next 12-18 months.
Market ExposureSTAA has large exposure to China, which is currently facing weaker economic conditions.
Sales PerformanceSales to China are still down year-over-year, though improved sequentially.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
STAA FAQ
What was Staar Surgical’s price range in the past 12 months?
Staar Surgical lowest stock price was $26.66 and its highest was $52.68 in the past 12 months.
What is Staar Surgical’s market cap?
Currently, no data Available
When is Staar Surgical’s upcoming earnings report date?
Staar Surgical’s upcoming earnings report date is Oct 30, 2024 which is 10 days ago.
How were Staar Surgical’s earnings last quarter?
Staar Surgical released its earnings results on Aug 07, 2024. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.239 by $0.151.
Is Staar Surgical overvalued?
According to Wall Street analysts Staar Surgical’s price is currently Undervalued.
Does Staar Surgical pay dividends?
Staar Surgical does not currently pay dividends.
What is Staar Surgical’s EPS estimate?
Staar Surgical’s EPS estimate is $0.18.
How many shares outstanding does Staar Surgical have?
Staar Surgical has 49,188,210 shares outstanding.
What happened to Staar Surgical’s price movement after its last earnings report?
Staar Surgical reported an EPS of $0.39 in its last earnings report, beating expectations of $0.239. Following the earnings report the stock price went up 11.032%.
Which hedge fund is a major shareholder of Staar Surgical?
Among the largest hedge funds holding Staar Surgical’s share is Defender Capital, LLC.. It holds Staar Surgical’s shares valued at 31M.
---
Staar Surgical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$43.00 (15.50% Upside)
$43.00 (15.50% Upside)
Blogger Sentiment
Bullish
STAA Sentiment 83%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 623.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $50.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 4.6%
Last 30 Days ▼ 4.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.62%
12-Months-Change
Fundamentals
Return on Equity
4.36%
Trailing 12-Months
Asset Growth
16.36%
Trailing 12-Months
Company Description
Staar Surgical
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.
---
STAA Earnings Call
Q2 2024
0:00 / 0:00
---
STAA Stock 12 Month Forecast
Average Price Target
$43.00
▲(15.50% Upside)
Technical Analysis
Best Analysts Covering STAA
1 Year
1 Year Success Rate
4/9 ratings generated profit
1 Year Average Return
+4.94%
reiterated a buy rating 4 months ago
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +4.94% per trade.
---